Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na<sub>V</sub>1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers.

Rothenberg, Michael E; Tagen, Michael; Chang, Jae H; Boyce-Rustay, Janel; Friesenhahn, Michel; Hackos, David H; Hains, Avis; Sutherlin, Dan; Ward, Michael; Cho, William

Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na_V1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers.

Rothenberg, Michael E; Tagen, Michael; Chang, Jae H; Boyce-Rustay, Janel; Friesenhahn, Michel; Hackos, David H; Hains, Avis; Sutherlin, Dan; Ward, Michael; Cho, William.

Afiliação

Rothenberg ME; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. rothenberg.michael@gene.com.
Tagen M; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Chang JH; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Boyce-Rustay J; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Friesenhahn M; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Hackos DH; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Hains A; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Sutherlin D; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Ward M; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Cho W; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.

Clin Drug Investig ; 39(9): 889-890, 2019 Sep.

Article em En | MEDLINE | ID: mdl-31338799

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Drug Investig Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google